-+ 0.00%
-+ 0.00%
-+ 0.00%

Evercore ISI Group Maintains Outperform on Medline, Raises Price Target to $44

Benzinga·11/05/2026 14:23:37
Listen to the news
Evercore ISI Group analyst Elizabeth Anderson maintains Medline (NASDAQ:MDLN) with a Outperform and raises the price target from $38 to $44.